UDG Healthcare plc An International Healthcare Services Organisation

Size: px
Start display at page:

Download "UDG Healthcare plc An International Healthcare Services Organisation"

Transcription

1 UDG Healthcare plc An International Healthcare Services Organisation Jefferies 2014 Global Healthcare Conference 2014 Liam FitzGerald, CEO 20 November

2 FORWARD LOOKING STATEMENTS Some statements in this presentation are forward-looking. They represent expectations for the Group s business and involve risks and uncertainties. UDG Healthcare plc has based these forward-looking statements on current expectations and projections about future events. The Group believes that expectations and assumptions with respect to these forward-looking statements are reasonable. However, because they involve known and unknown risks, uncertainties and other factors, which are in some cases beyond the Group s control, actual results or performance may differ materially from those expressed or implied by such forward-looking statements. 2

3 UDG Healthcare plc UDG Healthcare plc, is a leading international provider of outsourced healthcare solutions, operating across 3 divisions London Listed, FTSE 250 constituent Market Cap 800m Operating in 20 countries 2014 Revenue 2.13bn Over 8,300 employees 2014 Operating Profit 102.6m m Operating profit by division % 19% Sharp Packaging Services % 13% 23% 42% Ashfield Commercial & Medical Services 20 86% 64% 39% Supply Chain Services 0 100% Operating profit before amortisation of acquired intangible assets, acquisition costs and exceptional items

4 STRATEGY OUTSOURCE PARTNER OF CHOICE Capitalise on the increasing trend by Pharmaceutical and Medtech companies to outsource non-core and specialist activities. Group is organised in 3 divisions each focussed on specific solutions to healthcare companies. Create and sustain leading positions in our markets Extend into new markets with high growth opportunities Continually innovate existing and new services to meet clients needs Continue to build a growing, sustainable and cash generative business that is the outsource partner of choice in our specialist areas 4

5 Target selection Target validation Screening Lead optimization Clinical supply STRONG GROWTH TREND ACROSS HEALTHCARE OUTSOURCING Discovery Development Manufacturing Commercial Biopharma total spend ~$40B ~$80B ~$260B 2 ~$200B 1 Outsourced spend ~$13B ~$27B ~$132B ~$7B Outsourcing growth 10-20% 6-7% 6-8% 5-15% Typical services Pre-clinical Clinical API/bulk Formulated dose Packaging Medical Sales/Distribution Communication Distribution Other OUR AREAS OF FOCUS Note: Market sizes in Including sales, marketing, medical services and commercial R&D 2. Including outsourced logistics spend, but excluding internal spend on supply chain Source: Analyst and market reports; CEPTON; BCG analysis 5

6 BUSINESS OVERVIEW GLOBAL COMMERCIAL & MEDICAL SERVICES: SUPPLY CHAIN SERVICES : GLOBAL PACKAGING SERVICES: Sales & marketing (CSO & multi-channel) Healthcare communications Market access, PV & regulatory Pharma wholesale Pre-wholesale - bulk distribution Medical device sales & distribution Commercial packaging Clinical trials packaging & logistics Serialisation services No.1 UK & Europe Emerging in US / Japan Leading global position Emerging in US No.1 RoI and N Ireland No.1 RoI Leading in UK & Ireland No.2 CPO globally Emerging in clinical 42% of Group profits 8.7% Operating Margin 39% of Group profits 2.8% Operating Margin 19% of Group profits 10.7% Operating Margin 6

7 2014 HIGHLIGHTS FINANCIAL OPERATING STRATEGIC Operating profit up 9% in the year EPS ahead 8% despite disposals (guidance for 5-9%) Proposed 6% increase in dividend 25 years of consistent growth Strong performance across all divisions Ashfield operating profits 32% ahead, Japan profitable Sharp operating profits 22% ahead, Europe returned to profitability Supply Chain Services result impacted by disposals, wholesale increased market share Acquisitions of KP360 & Galliard establish Healthcare Comms market leadership Disposals realise cash enabling strategic investments Continued investment in functional capabilities and new capacity Successful re-branding - benefits emerging 7

8 2014 FINANCIAL SUMMARY FY 2014 FY 2013 % Increase Revenue 2,127m 2,033m 5% Operating profit (EBITA)* 102.6m 94.5m 9% PAT* 70.0m 64.4m 9% EPS (C)* % DPS (C) % Net debt / EBITDA (x) N/A Fx impact <1% negative impact year on year * Before amortisation of acquired intangible assets, acquisition costs and exceptional items comparatives adjusted for IAS 19 8

9 FINANCIAL HIGHLIGHTS OPERATING PROFIT ( m) OPERATING MARGIN % 4.40% 4.61% 4.65% 4.82% bp EPS (cent) DPS (cent) % (Cent) % Operating profit before amortisation of acquired intangible assets, acquisition costs and exceptional items

10 ASHFIELD 2014 OVERVIEW OPERATING PROFIT ( M) Division operating profits +32% to 43.3m Margin improved to 8.7% (+34bp) UK Operating Profits +18% 23 Growth driven by acquisitions (KP360/Galliard) US Operating Profits +40% Strong multi-channel and Medical Services performance - some acquisition benefit and one-off projects 13 Europe Operating Profits +18% Margins improved to 8% in H Leadership across 8 markets Japan Profitable for year, 2 years post setup Formalised J/V agreement with CMIC in October UK US / Canada Europe Japan 10

11 ASHFIELD OUTLOOK Market Market growing at 5% + for Commercial services Strong demand for multi-channel (combined CSO, nurse & call centre) solutions in US and UK Growth driven by increased penetration of Specialty and Biotech products Re-branding has been very beneficial Combining capabilities across different geographies KP360 ( 106m) & Galliard ( 16m) Acquisitions Created market leadership in Healthcare communications Healthcare communications 34% of Ashfield profits in 2014 will be ~ 40% in 2015 Strong growth in digital & multiplatform Significant synergies with other Ashfield businesses 2014 PROFIT SPLIT BY ACTIVITY 13% 34% 53% CSO Healthcare Comms Medical Services 11

12 SUPPLY CHAIN SERVICES OVERVIEW & OUTLOOK OPERATING PROFIT ( M) Division Operating profit down 13% to 40.2m Revenues of 1,452m (-2%) Margin declined 35bps to 2.8% Ex-disposals - profits down 6% Wholesale profits down 14% Generic reference pricing and Direct to Pharmacy (DTP) impact in H2 and FY 2015 Increased wholesale market share 15.0 Partial Disposal 0% Pre-Wholesale flat, despite UniDrug disposal in August Aquilant profit ahead 5% Disposal Outlook Pharma Wholesale Pre Wholesale Aquilant Specials DTP & Generic reference pricing along with loss of income from disposals will impact profitability in 2015 Expect market pressures to ease beyond 2015/2016 as market normalises Significant investment in operating efficiencies 12

13 SHARP 2014 OVERVIEW & OUTLOOK OPERATING PROFIT ( M) Division Operating Profits +22% to 19.1m Revenues of 179m (+7%) Margins improve to 10.7% (+126bp) US profit down 4% (flat in constant currency) serialisation costs and weather in H1 US strong recovery in H2 with 23% revenue increase and profit up over 50% on H1 EU: 0.1m profit a significant improvement, but more work to do US EU Total Outlook Strong momentum in US with good pipeline 9 lines serialised with 15 planned in 2015 Re-branding beginning to benefit EU Significant capacity being added to US with 35m expansion 13

14 FINANCIAL OUTLOOK Medium term organic profit growth potential Ashfield Commercial & Medical Services c.50% of profits 5 to 10% annual Sharp Packaging Services c.20% of profits 10% + annual Supply Chain Services c.30% of profits -5% to 2% annual Mix moving to higher growth, higher margin businesses 2015 Outlook Operating profit and EPS growth (on a constant currency basis) 14

15 FUTURE CAPITAL DEPLOYMENT ~30% Interest, tax, working capital EBITDA ~20% ~15% CapEx Typically CapEx = Depreciation 30% - 40% in FY14, 15, 16 (Sharp, SAP) Dividends Pay-out ratio 33% - 35% of EPS Balance Acquisitions / Debt Acquisitions primarily in Ashfield Target 15% ROCE in 3 years Debt leverage 1.89x, Covenants 3.5x 15

16 OUTLOOK Favourable market dynamics: Pharma require increased flexibility driving demand for specialist outsourced services across marketing, communication, distribution and packaging Well positioned for future growth 2 strongly growing global platforms in Ashfield and Sharp Strong domestic supply chain business, which remains cash generative Investing in functional capabilities and operating capacity across Group and will continue to focus on identifying efficiencies Re-branding has helped simplify and is benefitting business development Consistent EPS and dividend growth performance 16

17 17

Four brands reporting through three operating divisions

Four brands reporting through three operating divisions Annual Report 2014 Four brands reporting through three operating divisions Ashfield Commercial & Medical Services UDG Healthcare plc is a leading international provider of services to the healthcare industry.

More information

United Drug The International Healthcare Services Company

United Drug The International Healthcare Services Company United Drug The International Healthcare Services Company UDG ID / UDG LN FORWARD LOOKING STATEMENTS Some statements in this presentation are forward looking. They represent expectations for the Group

More information

TelecityGroup plc. First Half 2012 results 6 August 2012

TelecityGroup plc. First Half 2012 results 6 August 2012 TelecityGroup plc First Half 2012 results 6 August 2012 Cautionary note regarding forward-looking statements This presentation includes statements that are forward-looking in nature. All statements other

More information

DCC Overview DCC is an international sales, marketing, distribution and business support services group operating across four divisions

DCC Overview DCC is an international sales, marketing, distribution and business support services group operating across four divisions Company Overview DCC Overview DCC is an international sales, marketing, distribution and business support services group operating across four divisions Profit by division * Profit by geography * 14% 4%

More information

Investor & Analyst Presentation Acquisition of Centor US Holding Inc. Uwe Röhrhoff, CEO Rainer Beaujean, CFO Duesseldorf, July 28, 2015

Investor & Analyst Presentation Acquisition of Centor US Holding Inc. Uwe Röhrhoff, CEO Rainer Beaujean, CFO Duesseldorf, July 28, 2015 Investor & Analyst Presentation Acquisition of Centor US Holding Inc. Uwe Röhrhoff, CEO Rainer Beaujean, CFO Duesseldorf, July 28, 2015 Disclaimer 1. This presentation may contain certain forward-looking

More information

Reed Elsevier Results 2013 Erik Engstrom, CEO Duncan Palmer, CFO

Reed Elsevier Results 2013 Erik Engstrom, CEO Duncan Palmer, CFO Reed Elsevier Results Erik Engstrom, CEO Duncan Palmer, CFO FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the US Securities Act of

More information

IFGL REFRACTORIES LTD. RESULT UPDATE PRESENTATION, February 2016

IFGL REFRACTORIES LTD. RESULT UPDATE PRESENTATION, February 2016 IFGL REFRACTORIES LTD RESULT UPDATE PRESENTATION, February 2016 Safe Harbor This presentation and the accompanying slides (the Presentation ), has been prepared by IFGL Refractories Limited (the Company

More information

Q1/2015 Results VTG AG Connecting worlds. Dr. Heiko Fischer, CEO Dr. Kai Kleeberg, CFO May 21, 2015

Q1/2015 Results VTG AG Connecting worlds. Dr. Heiko Fischer, CEO Dr. Kai Kleeberg, CFO May 21, 2015 Q1/2015 Results VTG AG Connecting worlds Dr. Heiko Fischer, CEO Dr. Kai Kleeberg, CFO May 21, 2015 Table of content 1 Discussion of Q1/2015 2 Outlook FY 2015 3 Questions & Answers 4 Financial Calendar

More information

Preliminary Results 2015 23 September 2015

Preliminary Results 2015 23 September 2015 Preliminary Results 2015 23 September 2015 Forward-Looking Statements This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the

More information

Company Overview Presentation

Company Overview Presentation Company Overview Presentation December 2012 Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any shares or other securities

More information

Intertrust Sees Solid Performance in Q1

Intertrust Sees Solid Performance in Q1 Intertrust Sees Solid Performance in and expects Full Year Adjusted net income per share of at least 1.30 Intertrust N.V. results Amsterdam, April 21,, Intertrust N.V. ( Intertrust or Company ) [ticker

More information

Recall Holdings Limited 31 December 2013 Trading Update

Recall Holdings Limited 31 December 2013 Trading Update Document Management Solutions Secure Destruction Services Data Protection Services Recall Holdings Limited 31 December 2013 Trading Update February 19 th 2014 Presenters: CEO - Doug Pertz, CFO - Mark Wratten

More information

Interim Results 2015 12 March 2015

Interim Results 2015 12 March 2015 Interim Results 2015 12 March 2015 2015 Interim Highlights Adjusted diluted EPS of 5.80c underlying increase of 7.1% Group Revenue Agri-Services Operating Profit Share of Profit of Associates and JV Adjusted

More information

2015 annual results. 16 th March 2016

2015 annual results. 16 th March 2016 2015 annual results 16 th March 2016 Legal disclaimer Certain statements in this document are forward-looking statements. These forward-looking statements speak only as at the date of this document. These

More information

Q1 Trading Update, FY 2011

Q1 Trading Update, FY 2011 ARYZTA AG Q1 Trading Update, FY 2011 29 November 2010 Forward Looking Statement This document contains forward looking statements which reflect management s current views and estimates. The forward looking

More information

Alternative Networks plc Interim results for the six months to 31 March 2015

Alternative Networks plc Interim results for the six months to 31 March 2015 Alternative Networks plc Interim results for the six months to 31 March 2015 Edward Spurrier, Chief Executive Officer Mark Quartermaine, Chief Operating Officer (CEO Designate) Gavin Griggs, Chief Financial

More information

Conference Call Preliminary Full-Year Results 2014

Conference Call Preliminary Full-Year Results 2014 Conference Call Preliminary Full-Year Results 2014 Joachim Kreuzburg, CEO January 27, 2015 Disclaimer This presentation contains statements concerning the future performance of the Sartorius Group and

More information

Conference Call 9M 2015 Results

Conference Call 9M 2015 Results Conference Call 9M 2015 Results Joachim Kreuzburg, CEO October 20, 2015 Disclaimer This presentation contains statements concerning the future performance of the Sartorius Group and the Sartorius Stedim

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group JP Morgan Milan Investor Forum October 1, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

The importance of participating in European Consolidation. Goldman Sachs European Financials Conference 8th June 2006

The importance of participating in European Consolidation. Goldman Sachs European Financials Conference 8th June 2006 The importance of participating in European Consolidation Goldman Sachs European Financials Conference 8th June 2006 Forward Looking Statement 2 This document contains certain forward-looking statements

More information

Full year results. March 2012

Full year results. March 2012 2 0 1 1 Full year results March 2012 1 DISCLAIMER Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation

More information

N E W S R E L E A S E INTERIM MANAGEMENT STATEMENT

N E W S R E L E A S E INTERIM MANAGEMENT STATEMENT N E W S R E L E A S E 19 November 2015 INTERIM MANAGEMENT STATEMENT CRH plc, the international building materials group, issues the following Interim Management Statement in accordance with the reporting

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Commerzbank German Investment Seminar January 11/12, 2016 For detailed financial information please see our annual/quarterly reports and/or conference call materials

More information

Financial Information

Financial Information Financial Information Solid results with in all key financial metrics of 23.6 bn, up 0.4% like-for like Adjusted EBITA margin up 0.3 pt on organic basis Net profit up +4% to 1.9 bn Record Free Cash Flow

More information

MMS Group FY15 Results Presentation. August 2015

MMS Group FY15 Results Presentation. August 2015 August 2015 Group Overview 2 Overview MMS generated a record financial result in FY15 o EBITDA up 20%, NPAT up 23%, EPS up 18% MMS has entered a new stage in its evolution o Step change in scale, competitiveness

More information

CFO s presentation. CFO Jari Karlson

CFO s presentation. CFO Jari Karlson CFO s presentation CFO Jari Karlson Orion s financial objectives Increasing net sales. Achievement of this objective requires continuous investment in development of the product portfolio. Maintaining

More information

NEWS RELEASE 16 July 2008. Wolseley plc Pre-Close Period Trading Statement for the eleven months ended 30 June 2008

NEWS RELEASE 16 July 2008. Wolseley plc Pre-Close Period Trading Statement for the eleven months ended 30 June 2008 NEWS RELEASE 16 July 2008 Wolseley plc Pre-Close Period Trading Statement for the eleven months ended 30 June 2008 Wolseley plc, the world s largest specialist trade distributor of plumbing and heating

More information

Focus on fleet customers SAF-HOLLAND Annual Financial Statements 2013

Focus on fleet customers SAF-HOLLAND Annual Financial Statements 2013 Focus on fleet customers SAF-HOLLAND Annual Financial Statements 213 Detlef Borghardt, CEO Wilfried Trepels, CFO March 13, 214 Agenda 1 Financials 3 2 Appendix 21 2 Executive Summary 1 2 3 Group sales

More information

Introduction. Strong growth continues. Implementing the strategy - 3 - H2 Group revenue H1 Group revenue

Introduction. Strong growth continues. Implementing the strategy - 3 - H2 Group revenue H1 Group revenue !" #$% $ Disclaimer This presentation, prepared by IG Group Holdings plc (the Company ), contains forward-looking statements about the IG Group. By their very nature, forward-looking statements involve

More information

Edinburgh University Trading and Investment Club

Edinburgh University Trading and Investment Club Edinburgh University Trading and Investment Club Healthcare: Healthcare plc 500 450 400 350 300 250 200 150 100 50 0 Asset Name Ticket Symbol Market Analysts Sector-Heads Sub-Industry healthcare plc :LSE

More information

Delivering sustainable global growth

Delivering sustainable global growth Delivering sustainable global growth Driving profits by growing third party assets Keith Skeoch CEO, Standard Life Investments This presentation may contain certain forward-looking statements with respect

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Credit Suisse Global Health Care Conference, March 4, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials

More information

Credit Suisse Global Health Care Conference. March 5, 2013

Credit Suisse Global Health Care Conference. March 5, 2013 Credit Suisse Global Health Care Conference March 5, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results

More information

Restoring QinetiQ to Strength: Solid progress. QinetiQ Interim Results 2010 Thursday 18 th November 2010

Restoring QinetiQ to Strength: Solid progress. QinetiQ Interim Results 2010 Thursday 18 th November 2010 Restoring QinetiQ to Strength: Solid progress QinetiQ Interim Results 2010 Thursday 18 th November 2010 Leo Quinn Chief Executive Officer Agenda 1. Headlines 2. Financial overview 3. Operational update

More information

K+S Group FY/Q4 2014 Analyst conference. 12 March 2015, Frankfurt am Main. Norbert Steiner, CEO Dr. Burkhard Lohr, CFO

K+S Group FY/Q4 2014 Analyst conference. 12 March 2015, Frankfurt am Main. Norbert Steiner, CEO Dr. Burkhard Lohr, CFO Experience growth. FY/Q4 2014 Analyst conference 12 March 2015, Frankfurt am Main Norbert Steiner, CEO Dr. Burkhard Lohr, CFO Agenda A. FY 2014 Financials B. Projects and initiatives C. Q4 Financials D.

More information

Airbus Group Achieves Record Revenues, EBIT* And Order Backlog In 2014

Airbus Group Achieves Record Revenues, EBIT* And Order Backlog In 2014 Airbus Group Achieves Record Revenues, EBIT* And Order Backlog In Revenues increase five percent to 60.7 billion Reported EBIT* up 54 percent to 4.0 billion with a 6.7% return on sales Earnings per share

More information

650-527-5152 650-527-6273 SYMANTEC REPORTS FIRST QUARTER FISCAL YEAR 2016 RESULTS

650-527-5152 650-527-6273 SYMANTEC REPORTS FIRST QUARTER FISCAL YEAR 2016 RESULTS FOR IMMEDIATE RELEASE MEDIA CONTACT: INVESTOR CONTACT: Kristen Batch Sean Hazlett Symantec Corp. Symantec Corp. 650-527-5152 650-527-6273 kristen_batch@symantec.com sean_hazlett@symantec.com SYMANTEC REPORTS

More information

Full Year Results 2014

Full Year Results 2014 Full Year Results 2014 18 March 2015 Conference call on FY Results 2014 Corporate Finance & Investor Relations AGENDA FY 2014 results presentation Highlights 2014 Financials 2014 Outlook 2015 Appendix

More information

Telenor Group Third Quarter 2015. Sigve Brekke, CEO

Telenor Group Third Quarter 2015. Sigve Brekke, CEO Telenor Group Third Quarter 2015 Sigve Brekke, CEO Disclaimer The following presentation is being made only to, and is only directed at, persons to whom such presentation may lawfully be communicated (

More information

Ontex Q3 2015: Trading in line with Company expectations and full year outlook reiterated

Ontex Q3 2015: Trading in line with Company expectations and full year outlook reiterated Ontex Q3 2015: Trading in line with Company expectations and full year outlook reiterated Aalst-Erembodegem, November 5, 2015 - Ontex Group NV (Euronext Brussels: ONTEX; Ontex, the Group or the Company

More information

SAF-HOLLAND Annual Financial Statements 2012. Detlef Borghardt, CEO Wilfried Trepels, CFO. March 14, 2013

SAF-HOLLAND Annual Financial Statements 2012. Detlef Borghardt, CEO Wilfried Trepels, CFO. March 14, 2013 SAF-HOLLAND Annual Financial Statements 212 Detlef Borghardt, CEO Wilfried Trepels, CFO March 14, 213 Executive Summary business volume successfully expanded in 212 1 Group sales increased yoy by 3.4%

More information

Adecco returns to growth in October

Adecco returns to growth in October Adecco returns to growth in October Improving revenue trends and strong profitability in Q3 2013 Q3 2013 HIGHLIGHTS Revenues flat in constant currency Gross margin of 18.7%, up 80 bps SG&A down 2% in constant

More information

Measuring performance Update to Insurance Key Performance Indicators

Measuring performance Update to Insurance Key Performance Indicators Measuring performance Update to Insurance Key Performance Indicators John Hele Member of Executive Board and CFO of ING Group Madrid 19 September 2008 www.ing.com Agenda Performance Indicators: Background

More information

Deutsche Wohnen AG.» Considerations on Vonovia's offer. 22 October 2015

Deutsche Wohnen AG.» Considerations on Vonovia's offer. 22 October 2015 Deutsche Wohnen AG» Considerations on Vonovia's offer 22 October 2015 1 » Vonovia offer totally inadequate on multiple dimensions 1 Offer represents significant discount to stand-alone intrinsic value

More information

2 N D Q U A R T E R 2 0 1 6. O s l o, 1 8 J u l y 2 0 1 6

2 N D Q U A R T E R 2 0 1 6. O s l o, 1 8 J u l y 2 0 1 6 2 N D Q U A R T E R 2 1 6 O s l o, 1 8 J u l y 2 1 6 Agenda Per A Sørlie, President & CEO Highlights Business areas Outlook Per Bjarne Lyngstad, CFO Financial performance 2 Highlights 2 nd quarter 216

More information

Talent2 International Limited Analyst Presentation 2011 Full Year Results

Talent2 International Limited Analyst Presentation 2011 Full Year Results Talent2 International Limited Analyst Presentation 2011 Full Year Results Full Year Results FY 2011 FY 20 Growth Revenue $306.1m $242.6m 26% Gross Profit $194.0m $156.5m 24% Reported EBITDA $30.0m $19.8m

More information

Unless otherwise stated, references to 2007 are made in relation to the first half of the year.

Unless otherwise stated, references to 2007 are made in relation to the first half of the year. Standard Chartered PLC Pre-close Trading Update 26 June 2008 Standard Chartered PLC will be holding discussions with analysts and investors ahead of its close period for the half year ending 30 June 2008.

More information

Sharing a vision for the future. 2015 3 rd Quarter Trading Update. 30 th October 2015

Sharing a vision for the future. 2015 3 rd Quarter Trading Update. 30 th October 2015 Sharing a vision for the future 2015 3 rd Quarter Trading Update 30 th October 2015 On track to meet full-year EBITA and cash conversion targets Revenue: 3,892.5m +3.2% YTD, -0.7% in Q3 EBITA: 232.7m +5.7%

More information

Ludwigshafen, February 25, 2014

Ludwigshafen, February 25, 2014 Ludwigshafen, February 25, 2014 Analyst Conference FY2013 Cautionary note regarding forward-looking statements This presentation may contain forward-looking statements that are subject to risks and uncertainties,

More information

Klöckner & Co SE. Q3 2014 Results

Klöckner & Co SE. Q3 2014 Results Klöckner & Co SE A Leading Multi Metal Distributor Gisbert Rühl CEO Marcus A. Ketter CFO Results Analysts and Investors Conference November 6, Disclaimer This presentation contains forward-looking statements

More information

Company Presentation VTG AG Connecting worlds. Analyst Conference April 14, 2015

Company Presentation VTG AG Connecting worlds. Analyst Conference April 14, 2015 Company Presentation VTG AG Connecting worlds Analyst Conference April 14, 2015 Table of content 1 Highlights 2014 2 Performance & Financials 2014 3 Update on Strategy 4 Outlook 2015 5 Appendix 1 Executive

More information

Q1 2010 Results Analyst Presentation Henk van Dalen, CFO 3 May 2010

Q1 2010 Results Analyst Presentation Henk van Dalen, CFO 3 May 2010 Q1 2010 Results Analyst Presentation Henk van Dalen, CFO 3 May 2010 Overall trading conditions continue to improve GROUP Operating income 251 million ( 163 million in Q1 20); quarter benefited from four

More information

Results Presentation for Year Ended 30 June 2015 25 August 2015

Results Presentation for Year Ended 30 June 2015 25 August 2015 Results Presentation for Year Ended 30 June 2015 25 August 2015 Rene Sugo CEO Agenda Corporate Profile Financial Summary Business Overview TNZI Acquisition Update FY16 Roadmap 2 Corporate Profile 3 Corporate

More information

Analyst Conference Call

Analyst Conference Call 1 st December 2015 Analyst Conference Call Dr Wolfgang Büchele - CEO Disclaimer This presentation contains forward-looking statements about Linde AG ( Linde ) and their respective subsidiaries and businesses.

More information

John Menzies plc Final Results Presentation. 11 March 2008

John Menzies plc Final Results Presentation. 11 March 2008 John Menzies plc Final Results Presentation 11 March 2008 Agenda Group Highlights and Financial Review Business Review Menzies Aviation Business Review Menzies Distribution Summary Questions 2 John Menzies

More information

INTRODUCTION TO HOGG ROBINSON GROUP plc

INTRODUCTION TO HOGG ROBINSON GROUP plc INTRODUCTION TO HOGG ROBINSON GROUP plc Contents Pages Introduction to Hogg Robinson Group 3-10 Business model and competitive advantages 3 Strategy 4 Financial performance 5 KPIs 6 Clients and contracts

More information

Strong Q2 Outlook increased

Strong Q2 Outlook increased www.osram.com Strong Q2 Outlook increased Q2 FY15 Management Presentation (preliminary figures) April 29, 2015 Light is OSRAM Safe Harbor Statement This presentation may contain forward-looking statements

More information

Organic Growth and Strategic Acquisitions. Delivered record 66 million of validated cost savings to our customers

Organic Growth and Strategic Acquisitions. Delivered record 66 million of validated cost savings to our customers 2014 Preliminary Results For the year ended 31 December 2014 Organic Growth and Strategic Acquisitions Delivered record 66 million of validated cost savings to our customers Agenda Overview Financial highlights

More information

GrandVision reports Revenue growth of 13.8% and EPS growth of 31.7%

GrandVision reports Revenue growth of 13.8% and EPS growth of 31.7% GrandVision reports Revenue of 13.8% and EPS of 31.7% Schiphol, the Netherlands 16 March 2015. GrandVision NV (EURONEXT: GVNV) publishes Full Year and Fourth Quarter 2015 results. 2015 Highlights Revenue

More information

Preliminary results for the year ended 31 March 2015

Preliminary results for the year ended 31 March 2015 Preliminary results for the year ended 31 March 2015 Highlights Second phase of our transformational journey Performance in line with expectations; progress across all key focus areas Pre-exceptional operating

More information

Business Case. June 2016

Business Case. June 2016 Business Case June 2016 About us Bunzl is a growing and successful Group providing outsourcing solutions and value added distribution across the Americas, Europe and Australasia Source Consolidate Deliver

More information

Market Segmentation Strategy

Market Segmentation Strategy 2015 Interim Results For the six months ended 30 June 2015 Further market share gains in challenging markets Agenda Overview Financial highlights Market drivers Growth Strategy Key Accounts Insites TM

More information

2016 Interim Results Presentation 24 November 2015

2016 Interim Results Presentation 24 November 2015 2016 Interim Results Presentation 24 November 2015 Disclaimer This presentation includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements can be

More information

Creating an international pharmacy-led healthcare group

Creating an international pharmacy-led healthcare group 3 October 2005 Alliance Boots plc 1 Legal disclaimer This presentation does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy any security, nor shall there be any

More information

Halma has a very long record of growing its dividend, increasing it by 5% or more for every one of the last 35 years.

Halma has a very long record of growing its dividend, increasing it by 5% or more for every one of the last 35 years. Financial Review Long-term model delivering widespread growth This is another set of record results with widespread growth in all sectors and all regions. High returns were maintained and good cash generation

More information

GUD half year results Six months ended 31 December 2015. Jonathan Ling Managing Director

GUD half year results Six months ended 31 December 2015. Jonathan Ling Managing Director GUD half year results Six months ended 31 December 2015 Jonathan Ling Managing Director Result key points Reported NPAT of $1.7 million down from $17.3 million previously Includes $18.5 million after tax

More information

Second Quarter 2015 Investor Conference Call

Second Quarter 2015 Investor Conference Call Second Quarter 2015 Investor Conference Call August 20, 2015 December 13, 2012 DRAFT 5 Safe Harbor Basis of Presentation Unless otherwise noted or unless the context otherwise requires, all references

More information

Standard Life plc Half year results 2015 4 August 2015

Standard Life plc Half year results 2015 4 August 2015 Standard Life plc Half year results 2015 4 August 2015 Focus on fee business driving growth and performance Fee based revenue, including Ignis, up 17% to 761m with 95% of income now fee based Assets under

More information

The Annual Analyst Conference will take place in London, on November 9, at 11 a.m. UK time, and will be webcast on www.siemens.com/investorrelations

The Annual Analyst Conference will take place in London, on November 9, at 11 a.m. UK time, and will be webcast on www.siemens.com/investorrelations Siemens Q4 FY07 Flashlight The Annual Analyst Conference will take place in London, on November 9, at 11 a.m. UK time, and will be webcast on www.siemens.com/investorrelations The Press Conference will

More information

Telenor Group Fourth Quarter 2015. Sigve Brekke, CEO

Telenor Group Fourth Quarter 2015. Sigve Brekke, CEO Telenor Group Fourth Quarter 2015 Sigve Brekke, CEO Disclaimer The following presentation is being made only to, and is only directed at, persons to whom such presentation may lawfully be communicated

More information

Aalberts Industries Net profit and earnings per share +15%

Aalberts Industries Net profit and earnings per share +15% PRESS RELEASE 1 ST HALF YEAR 2015 Aalberts Industries Net profit and earnings per share +15% Langbroek, 13 August 2015 Highlights o Revenue EUR 1,244 million, increase +18% (organic +2%). o Operating profit

More information

Interim financial report third quarter 2014 Investor presentation. Koen Van Gerven, CEO Pierre Winand, CFO

Interim financial report third quarter 2014 Investor presentation. Koen Van Gerven, CEO Pierre Winand, CFO Interim financial report third quarter 204 Investor presentation Koen Van Gerven, CEO Pierre Winand, CFO Brussels November, 4th 204 Investor presentation - Interim financial report 3Q4 2 Financial Calendar

More information

FY RESULTS 27 FEBRUARY 2015. Tom Enders I Chief Executive Officer Harald Wilhelm I Chief Financial Officer

FY RESULTS 27 FEBRUARY 2015. Tom Enders I Chief Executive Officer Harald Wilhelm I Chief Financial Officer 1 FY RESULTS 27 FEBRUARY 2015 Tom Enders I Chief Executive Officer Harald Wilhelm I Chief Financial Officer SAFE HARBOUR STATEMENT 2 Disclaimer This presentation includes forward-looking statements. Words

More information

Aalberts Industries increases earnings per share +10%

Aalberts Industries increases earnings per share +10% Aalberts Industries increases earnings per share +10% Langbroek, 26 February 2015 Highlights o Revenue EUR 2,201 million, increase +8% (organic +3.1%) o Operating profit (EBITA) +10% to EUR 247 million;

More information

Delivering Our vision, our future. Full year results for the year ended 31 March 2016

Delivering Our vision, our future. Full year results for the year ended 31 March 2016 Delivering Our vision, our future Full year results for the year ended 31 March 2016 Safe harbour statement The information contained in this presentation may include forward looking statements about e2v

More information

A LEADING GLOBAL HEALTHCARE COMPANY

A LEADING GLOBAL HEALTHCARE COMPANY A LEADING GLOBAL HEALTHCARE COMPANY Roadshow Boston March 2, 2016 Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains

More information

2014 HALF YEAR RESULTS 4 September 2014

2014 HALF YEAR RESULTS 4 September 2014 862m H1 2014 Revenues 2014 HALF YEAR RESULTS 4 September 2014 57% of Revenues for International in H1 2014 21,657 Employees In H1 2014 Disclaimer This presentation contains forward-looking statements (as

More information

Results Presentation. Half-Year Ended 31 December 2011. ASX Code: SAI. Tony Scotton Chief Executive Officer. 15 February 2011

Results Presentation. Half-Year Ended 31 December 2011. ASX Code: SAI. Tony Scotton Chief Executive Officer. 15 February 2011 Our compliance business has driven profit growth across the group despite reduced activity levels in our property business and the currency headwinds Tony Scotton Chief Executive Officer Results Presentation

More information

For Immediate Release February 9, 2016. Hinduja Global Solutions Limited

For Immediate Release February 9, 2016. Hinduja Global Solutions Limited PRESS RELEASE For Immediate Release February 9, 2016 Hinduja Global Solutions Limited FY2016 Consolidated Performance Highlights Net Sales of Rs. 8,829 million, an increase of 20.5% y-o-y EBITDA of Rs.

More information

NURSE & ALLIED STAFFING CLINICAL TRIALS SERVICES EDUCATION & RETAINED SEARCH

NURSE & ALLIED STAFFING CLINICAL TRIALS SERVICES EDUCATION & RETAINED SEARCH NURSE & ALLIED STAFFING CLINICAL TRIALS SERVICES EDUCATION & RETAINED SEARCH May 2008 This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or

More information

Applus+ Group Results Presentation First Quarter 2015 7 May 2015

Applus+ Group Results Presentation First Quarter 2015 7 May 2015 Applus+ Group Results Presentation First Quarter 2015 7 May 2015 DISCLAIMER This document may contain statements that constitute forward looking statements about Applus Services, SA ( Applus+ or the Company

More information

Etisalat Group. Q4 2014 Results Presentation

Etisalat Group. Q4 2014 Results Presentation Etisalat Group Q4 2014 Results Presentation 26 th February 2015 Disclaimer Emirates Telecommunications Corporation and its subsidiaries ( Etisalat or the Company ) have prepared this presentation ( Presentation

More information

1H15 Results Presentation

1H15 Results Presentation 23 February 2015 1H15 Results Presentation David Stewart CEO and Managing Director Ken Sheridan CFO and Executive Director TODAY S AGENDA M2M: An exciting opportunity New partnerships New products from

More information

Investor Day, February 2005. Veli-Matti Mattila CEO

Investor Day, February 2005. Veli-Matti Mattila CEO Investor Day, February 2005 Veli-Matti Mattila CEO 1 Contents CEO priorities Strategy and focus Financial targets Capital structure and profit distribution Current regulatory environment Summary 2 CEO

More information

Q2 and H1 2014 FINANCIAL RESULTS. 29 August 2014

Q2 and H1 2014 FINANCIAL RESULTS. 29 August 2014 Q and H1 014 FINANCIAL RESULTS 9 August 014 Forward Looking Statements This Presentation may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management

More information

Speech of the Board of Management. General Shareholders Meeting, 9 June 2015

Speech of the Board of Management. General Shareholders Meeting, 9 June 2015 Speech of the Board of Management General Shareholders Meeting, 9 June 2015 AGENDA Overview of the financial year Steven Holland, CEO Financial figures 2014 Georg Müller, CFO ConnectingChemistry Steven

More information

H1 2015 RESULTS INVESTOR PRESENTATION

H1 2015 RESULTS INVESTOR PRESENTATION Transforming MLB into a growing solutions led business with higher quality earnings (ASX : MLB) H1 2015 RESULTS INVESTOR PRESENTATION TABLE OF CONTENTS VISION AND STRATEGY H1 2015 FINANCIALS OPERATIONAL

More information

Investor Presentation 2010 Financial Results Full Year ended 30 June. Rebecca Norton, Chief Financial Officer

Investor Presentation 2010 Financial Results Full Year ended 30 June. Rebecca Norton, Chief Financial Officer Investor Presentation 2010 Financial Results Full Year ended 30 June Simon Full Year Woodfull, results Group CEO for year ended Rebecca Norton, Chief Financial Officer August 2010 AGENDA Group Highlights

More information

2014 results presentation for media and investors. Zurich, March 26, 2015

2014 results presentation for media and investors. Zurich, March 26, 2015 2014 results presentation for media and investors Zurich, Agenda 1 Introduction and executive summary 2 2014 results 3 A multi-dimensional transformation 4 Outlook Slide 2 Valora is moving in the right

More information

Company Overview Presentation

Company Overview Presentation Company Overview Presentation May 2012 Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any shares or other securities of DCC

More information

Health Care Worldwide. Citi - European Credit Conference September 24, 2015 - London

Health Care Worldwide. Citi - European Credit Conference September 24, 2015 - London Health Care Worldwide Citi - European Credit Conference September 24, 2015 - London Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties.

More information

Spire Healthcare Group Plc. Jefferies London Healthcare Conference November 2014

Spire Healthcare Group Plc. Jefferies London Healthcare Conference November 2014 Spire Healthcare Group Plc Jefferies London Healthcare Conference November 2014 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group

More information

ITW Conference Call Third Quarter 2013

ITW Conference Call Third Quarter 2013 ITW Conference Call Third Quarter 2013 October 22, 2013 SOLID GROWTH. STRONG RETURNS. BEST-IN-CLASS OPERATOR. Forward-Looking Statements Safe Harbor Statement This conference call contains forward-looking

More information

Investors/Analysts Conference London/New York, February 2012 Ian Bishop

Investors/Analysts Conference London/New York, February 2012 Ian Bishop Investors/Analysts Conference London/New York, February 2012 Ian Bishop This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as

More information

Presentation annual results 2013

Presentation annual results 2013 Presentation annual results 2013 Amsterdam, 21 February 2014 René J. Takens, CEO Hielke H. Sybesma, CFO Jeroen M. Snijders Blok, COO Agenda 1. Accell Group in 2013 2. The Accell Group share 3. Financials

More information

Confident progress delivering transformation

Confident progress delivering transformation Confident progress delivering transformation Q2 & half year results 2005/6 10th November 2005 BT Group plc Half year results 2005/6 Sir Christopher Bland -Chairman Forward-looking statements - caution

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Goldman Sachs - Leveraged Finance Healthcare Conference March 4, 2014 New York Goldman Sachs Leveraged Finance Conference, Fresenius SE & Co. KGaA Copyright, March 4, 2014 Page 1

More information

Q2 F2016 Conference Call

Q2 F2016 Conference Call Q2 F2016 Conference Call Driving Value April 28, 2016 Cautionary Statement Information in this presentation relating to projected growth and financial performance of the Company s business units, contribution

More information

FY 2006 Investor Update. Downer EDI Limited 2006 1

FY 2006 Investor Update. Downer EDI Limited 2006 1 FY 2006 Investor Update Downer EDI Limited 2006 1 Brent Waldron Deputy CEO Downer EDI Downer EDI Limited 2006 2 Australia s Leader in Engineering and Maintaining Essential Infrastructure Operations Markets

More information

Acquisition of SAIT Communications. 28 July 2015

Acquisition of SAIT Communications. 28 July 2015 Acquisition of SAIT Communications 28 July 2015 Conference call details SpeedCast acquires SAIT Communications The company has scheduled a conference call as follows: Time: 11.00am (Sydney time), 28 th

More information